OASIS neuropsychiatry

Company Overview

Snapshot

Founded in June 2025 by Benjamin Soffer, OASIS neuropsychiatry operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing its quantum EEG technology.

Business overview

OASIS neuropsychiatry is dedicated to transforming mental healthcare through quantum neuroscience. The company's core technology involves advanced quantum EEG, which provides detailed insights into brain function by precisely measuring neural activity patterns. This technology enables real-time brain activity monitoring, predictive treatment response algorithms, and personalized therapy recommendations. The platform is built on rigorous scientific research and clinical validation, aiming to establish a new standard of care by leveraging real-time brain data and building the largest EEG-outcomes database in neuropsychiatry. The company operates within the Health Tech & Life Sciences sector, specifically targeting Digital Healthcare and Digital Therapeutics markets.

Company Intelligence Q&A

What is OASIS neuropsychiatry's primary focus?

OASIS neuropsychiatry is focused on revolutionizing mental health through quantum EEG technology, aiming to establish a new standard of care using real-time brain data and a comprehensive EEG-outcomes database.

When was OASIS neuropsychiatry founded?

OASIS neuropsychiatry was founded in June 2025.

Who is a key founder of OASIS neuropsychiatry?

Benjamin Soffer is a co-founder of OASIS neuropsychiatry.

What technology does OASIS neuropsychiatry utilize?

OASIS neuropsychiatry utilizes advanced quantum EEG technology to provide insights into brain function and enable precise measurement of neural activity patterns.

What is OASIS neuropsychiatry's vision?

OASIS neuropsychiatry's vision is to establish a new standard of care through real-time brain data and the largest EEG-outcomes database in neuropsychiatry.